Search

everythinglearnresearchcommunity

for

Search:↓

Tissue expansion is an effective treatment for certain types of hair loss, providing immediate coverage with hair-bearing skin.

Different types of scarring alopecia may be stages of one disease, and accurate diagnosis is crucial to prevent permanent hair loss.

Transverse scalp biopsies are more accurate for diagnosing non-cicatricial alopecia, but examining both types is best for accuracy.

Oral minoxidil can potentially increase hair growth in people suffering from Central Centrifugal Cicatricial Alopecia.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

Some women with common hair loss may develop permanent hair loss.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

Seborrhoeic dermatitis may cause a condition called "seborrhoeic folliculitis," leading to chronic scalp inflammation and scarring hair loss.

Hydroxychloroquine can help treat certain types of hair loss.

Widened sweat ducts are a very specific sign of scarring hair loss.

Cicatricial alopecia causes permanent hair loss and is treated to relieve symptoms and stop progression.

Title change to "Central Centrifugal Cicatricial Alopecia (CCCA)"; common in African American women; hair-grooming methods may contribute; no effective therapy found; trials needed.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

The study found that Central Centrifugal Cicatricial Alopecia mainly affects middle-aged African descent women, is linked to certain hair care practices and genetics, and often goes undiagnosed for years.

Altered retinoid metabolism in cicatricial alopecia suggests a balanced vitamin A diet may prevent the condition.

CK15 is not a reliable marker for stem cells in damaged hair follicles from patients with CCCA.

Hyaluronic acid injections can cause hair loss due to blocked blood vessels.

Naked hair shafts are significantly associated with scarring hair loss and may help diagnose it, especially when multiple are found.

Certain health conditions and hair care habits affect the treatment results for a scalp condition called Central Centrifugal Cicatricial Alopecia.

A woman's scalp infection caused by a fungus led to permanent hair loss and was hard to treat but responded to a specific antifungal.

CCCA may be caused by both hair traction and an immune response.

CCCA is a scarring hair disorder mainly affecting people of African descent, needing better awareness and treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Some factors like thyroid disease, diabetes treatment, hair dryers, natural hairstyles, and scalp conditions can affect the treatment results for a hair loss condition called CCCA.

Seborrheic dermatitis may contribute to the development of central centrifugal cicatricial alopecia.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.